Aquinox Pharma (AQXP) Prices 5.35M Common Stock Offering at $12.25/Share

September 20, 2016 6:10 AM EDT

Find out which companies are about to raise their dividend well before the news hits the Street with's Dividend Insider Elite. Sign-up for a FREE trial here.

Aquinox Pharmaceuticals, Inc. (Nasdaq: AQXP) announced the pricing of an underwritten public offering of 5,350,000 shares of its common stock at a price to the public of $12.25 per share. In addition, Aquinox has granted the underwriters a 30-day option to purchase up to 802,500 additional shares of common stock at the public offering price. The offering is expected to close on September 23, 2016, subject to customary closing conditions.

Leerink Partners LLC, Canaccord Genuity and Guggenheim Securities are acting as joint book-running managers for the offering. Needham & Company is acting as lead manager.

A shelf registration statement relating to the offered shares of common stock was filed with the Securities and Exchange Commission (SEC) on December 21, 2015, which was declared effective on January 26, 2016. A preliminary prospectus supplement related to the offering has been filed with the SEC and is available on the SEC’s website, located at Copies of the preliminary prospectus supplement and the accompanying prospectus relating to this offering may be obtained from Leerink Partners LLC, Attention: Syndicate Department, One Federal Street, 37th Floor, Boston, MA, 02110, by telephone at (800) 808-7525 ext. 6142 or by email at; from Canaccord Genuity Inc., Attn: Syndicate Department, 99 High Street, Floor 12, Boston, MA 02110, by telephone at (617) 371-3900 or by email at; or from Guggenheim Securities, LLC, Attention: Equity Syndicate Department, 330 Madison Avenue, 8th Floor, New York, NY 10017, by telephone at (212) 518-9658 or by email at

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Corporate News, Equity Offerings

Related Entities

Needham & Company, Canaccord Genuity, Guggenheim

Add Your Comment